ABSTRACT Central cholinergic hypofunction causes the disruption of spatial cogni tion, while cholinomimetics improve this disruption in rats. Scopolamine (0.5 mg/kg, i.p.) has also been reported to disrupt radial maze performance in rats. Nebracetam (WEB 1881 FU), a new nootropic candidate, was able to correct this scopolamine-in duced disruption of spatial cognition at the dose of 10 mg/kg, p.o. Furthermore, neb racetam enhanced oxotremorine-induced tremors in mice. These results indicate that nebracetam has a cholinergic enhancing effect. The scopolamine-induced disruption of spatial cognition has been previously reported to improve not only by cholinomimetics but also by brain noradrenergic drugs such as L-threo-DOPS and amantadine. Neb racetam reversed the change of brain noradrenaline contents in the frontal cortex and hippocampus in which the noradrenaline content decreased by treatment with scopola mine. Nebracetam also decreased the d 9-tetrahydrocannabinol (6 mg/kg, i.p.)-in duced disruption of spatial cognition, which was reported to be related to the lymbic noradrenergic function. These results suggest that the cognitive enhancing effect of nebracetam involves not only cholinergic mechanisms but also involves lymbic and hippocampal noradrenergic mechanisms.
In cerebrovascular or Alzheimer's disease, cholinergic hypofunction generally causes de mentia such as memory loss or disorientation (1, 2) . Tetrahydroaminoacridine, a cholinergic enhancer, has been shown to improve these symptoms in patients with dementia (3) . From these cholinergic hypotheses, cholinergic an tagonist scopolamine is now widely used in animal experiments for memory disturbance. Scopolamine has been shown to disrupt pas sive avoidance performance (4, 5) and maze performance in rats (6) . Cholinergic enhancers such as physostigmine (5) tetrahydroamino acridine (7) and oxotremorine (8) have also been found to improve these deficits of mem ory performance.
Furthermore, our previous report suggested that the scopolamine-induced disruption of spatial cognition was rectified not only by cho linergic drugs but also by noradrenergic drugs such as L-threo-DOPS and amantadine (9) . These effects may be due to noradrenergic a 1 receptor stimulation, because the retrieval effects of L-threo-DOPS or amantadine were inhibited by the a 1-blocker prazosin (9) . Biochemical studies also indicated the norad renergic involvement of spatial cognition on 8 arm radial maze performance in rats. Scopola mine decreased the brain NA contents in the frontal cortex and the hippocampus in accord ance with the disruption of spatial cognition (9, 10) .
In addition, z 9-tetrahydrocannabinol (THC), one of the major constituents of marihuana, also disrupted the spatial cognition of rats (11) . the THC-induced disruption of spatial cognition was improved by either noradrena line (NA) or serotonin-related compounds but not by antidepressant drugs. From these findings, the THC-induced disruption of spa tial cognition was thought to be more related to the lymbic monoamine system than to the cholinergic system (11) .
Nebracetam (4-aminomethyl-l-benzylpyrro lidine-2-one-hemifumarate: WEB 1881 FU) is being developed as a novel compound that possesses both nootropic and cholinomimetic properties in animal studies (12) . Nebracetam also possesses cholinergic receptor affinity, especially towards Ml receptors (12, 13) . In the present study, to investigate whether neb racetam possesses an ameriorative effect on the disruption of spatial cognition and cho linergic and noradrenergic involvement, the drug's affect on scopolamine and THC-in duced disruption of spatial cognition were also examined using an 8-arm radial maze perform ance test in rats. In this experiment, the effect of nebracetam was compared with that of anir acetam, which is a benzylpyrrolidine derivative similar to nebracetam.
MATERIALS AND METHODS

Experiment 1: Eight arm radial maze task
Male Wistar rats weighing 200 250 g, sup plied by Kyu-Do Co., Ltd. (Saga, Japan), were used for this experiment and were kept on a constant light-dark cycle (light 0700 1900) with a restricted diet (CE-2, Clea, Japan) in an air conditioned room (23 ± 1°C, 60% humidity). Each rat was placed on a plat form (25 cm in diameter) in the middle of an 8-arm radial maze, in which each arm had been baited with a food pellet. Performance of the animal in each session was assessed by three parameters: the number of correct choices, the number of errors which was de fined as choosing arms that had already been visited, and the time elapsed before the ani mal ate all 8 pellets. The behavioral observation was discontinued after 10 min even if the animal did not finish the task.
In the drug test phase, we used only rats that had acquired spatial cognition; i.e., the rats that had made 7 or more correct choices and either one or no errors during the first 8 choices in each of 3 consecutive sessions. Sig nificantly decreased correct choices in the pres ence of significantly increased errors were con sidered to demonstrate a disruption of spatial cognition. Spatial cognition in the affected animals was considered to be improved when the drug-state rats made significantly increased correct choices and significantly decreased errors as compared with untreated affected animals.
Nebracetam (Boehringer Ingelheim, Ger many, dissolved in water) was orally adminis tered 60 min before each session. Aniracetam (Nippon Roche, Japan, suspended in 0.5% CMC-Na) was also orally administered 60 min before the session. Scopolamine (Sigma, USA, dissolved in physiological saline) was intraperi toneally administered 30 min before the ses sion. THC, isolated from cannabis by Prof. I. Nishioka and Y. Shoyama (Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Kyushyu University), was suspended in 1% Tween 80 and then intraperitoneally administered 60 min before the session.
Wilcoxon's rank sum test was used for the data analysis in these experiments. Experiment 2: Effects on brain NA levels Only male Wistar rats that had been trained in the 8-arm radial maze task and had sucess fully performed this task were used in this ex periment. Brain NA levels were studied in rats whose spatial cognition in the 8-arm radial maze was disrupted by scopolamine and whose scopolamine-induced disruption of spatial cognition was then improved by nebracetam using high performance liquid chromatography with electrochemical detection (HPLC-ECD).
Following the observation of maze perform ance, the rats were sacrificed by decapitation and the brain was immediately removed. The brain was cut into 1-mm coronal cryosections and punched out on an ice-cooled glass stage (Fig. 1) . The regional samples were homog enized in 200 ,u l of 0.5 M-PCA containing 0.05% Na2EDTA and 0.1% Na2S2O5 (All rea gents for HPLC studies were purchased from Sigma, USA). Following centrifugation, the supernatant was injected into a HPLC-ECD. The HPLC system (Waters Assoc., Milford, MA) utilized a Shodex ODS column (Showa Denko, Tokyo, Japan) set at a potential of +0.75 V versus the reference electrode. The HPLC mobile phase was 0.1 M citrate-phos phate buffer containing 1.5 mM sodium octyl sulphate (PIC-B8) and 11% methanol with 20 ,u M Na2EDTA (14) . The flow rate was main tained at 0.9 ml/min. Brain NA contents were quantified by calculating the area under the curves using an integrater (Waters Model 730, Waters Assoc. ), and their contents were deter mined based on standard curves.
Either Student's t-test or the Cochran-Cox test were used to determine the significances in NA contents. Experiment 3: Oxotremorine-induced tremors To investigate whether nebracetam reverses the disruption of spatial cognition by stimulat ing cerebral acetylcholinergic pathways or some other mechanisms, nebracetam was stud ied for its possible potentiating effect on tre mors induced by oxotremorine which acts directly on muscarinic acetylcholine (ACh) re ceptors.
Five-week-old male ddY mice weighing 20 25 g, supplied by Seiwa Experimental Animals (Fukuoka, Japan), were used in this experi ment. They were kept under the same condi tions as described above. Oxotremorine (Sig ma, USA) was dissolved in 0.9% physiological saline and was intraperitoneally administered. Nebracetam was first orally administered for 50 min and then intraperitoneally administered for 20 min before the oxotremorine treatment. Observations for tremors was made at 5-min intervals starting 30 min after the oxotremor ine treatment. The severity of tremors was scored according to 5 grades: 0: absent, 1: mild, 2: moderate, 3: marked, and 4: severe.
The Mann Whitney-U test was used for this experiment.
Experiment 4: Spontaneous motor activity and behavioral toxicity
Male Wistar rats were used for this experi ment. Spontaneous motor activity was meas ured with Hall's open-field apparatus (60-cm bottom diameter) (15) , and the numbers across the line were measured for 3 min. In testing the behavioral toxicity of nebracetam, the incidence of muscle relaxation was meas ured by a digital traction meter (Model F-1, Muromachi Kikai, Japan). When each rat was placed on the sliding table of the apparatus and was slowly pulled by his tail, forepaw re sistance was detected by a sensor. The motor co-ordination was also measured by a rota-rod apparatus (Muromachi Kikai, Japan). The rats were tested for the incidence of catalepsy by placing both forepaws on the horizontal bar (12-cm high), and the cataleptogenic effect was assessed as positive when the rat main tained this position for longer than 1 min. The rectal temperature was measured by a digital thermometer.
The Mann Whitney-U test and Fisher's ex act probability test were used to analyze the data from these experiments.
RESULTS
Experiment 1: Eight arm radial maze task
Effects on scopolamine-induced disruption of spatial cognition: The rats which had acquired spatial cognition in the 8-arm radial maze made approximately 8 correct choices and 0 errors in the first 8 choices (N = 21). Scopola mine at 0.5 mg/kg, i.p. significantly decreased the number of correct choices and significantly increased errors (N = 21), indicating that dis ruption of spatial cognition had occurred.
The effects of the oral administration of the test drug nebracetam on the scopolamine-in duced disruption of spatial cognition were in vestigated at doses of 5 to 50 mg/kg (N = 7 9). At 10 mg/kg (N = 9), nebracetam signifi cantly increased the number of correct choices and significantly decreased the errors in scopolamine-treated rats, suggesting that spa tial cognition disruption was decreased. How ever, at a dose of 20 mg (N = 8) or 50 mg/kg (N = 7), nebracetam did not improve this dis ruption of spatial cognition (Fig. 2) . Anirace tam significantly decreased the scopolamine induced disruption of spatial cognition at a dose of 50 mg/kg, p.o. (N = 9, Fig. 3 ).
Effects on THC-induced disruption of spatial cognition: In rats that had acquired spatial cognition, the intraperitoneal administration of THC at 6 mg/kg significantly decreased the number of correct choices while significantly increasing the errors (N = 11), suggesting a disruption of the spatial cognition. The THC induced disruption was expressed differently from the scopolamine-induced one: some rats hesitated to enter the first arm, while others just went up and down whatever arm they first encounterd.
The effects of nebracetam at 20 to 200 mg/kg, p.o. (N = 3-10) on these characteris tic features in the disruption of spatial cogni tion were studied. A significant improvement in spatial cognition was observed in the ani mals treated with 100 mg/kg (N = 10, Fig. 4) . Experiment 2: Effects on brain NA levels In this experiment, the detection limit of NA was about 10 pg according to the calibra tion curves (data not shown), which still enough to detect the content in small NA samples from brain tissue.
In non-trained intact control rats, one hour after the oral administration of nebracetam at 10 mg/kg (N = 5), the NA levels in the ven tral region of the hippocampus were signifi cantly higher than those of the corresponding controls (Fig. 6) .
Brain NA levels in the frontal cortex, dorsal and ventral hippocampus, lateral hypothala mus and medial amygdala (N = 13) were sig nificantly decreased in rats with scopolamine induced disruption of spatial cognition (N = 11). The oral administration of nebracetam (10 mg/kg, p.o.) improved spatial cognition while brain NA levels in the frontal cortex, dorsal and ventral hippocampus as well as the amygdala were normalized to normal control levels (N = 6, Fig. 7 ).
Experiment 3: Oxotremorine-induced tremors
The mice that were intraperitoneally treated with oxotremorine at 0.5 mg/kg, i. (N = 8, Fig. 9 ). In addition, aniracetam also did not affect ambulation in this experiment at 20 to 100 mg/kg (N = 8, Fig. 9 ). The frequen cy of rearing decreased by nebracetam at 50 mg/kg, p.o., but not at the other doses tested. Aniracetam also did not affect ambulation in this experiment at 20 to 100 mg/kg (N = 8, Fig. 9 ). To confirm the behavioral toxicity of the drug, motor coordination, muscle tone, in cidence of catalepsy and rectal temperature were all tested at larger drug doses than those used for the cognitive experiments. Both neb racetam and aniracetam caused neither motor uncoordination nor catalepsy (N = 8, data not shown). These drugs also had no affect on muscle tone (N = 8, Fig. 9 ). Nebracetam raised the rectal temperature at 100 and 200 mg/kg, p.o., but did not cause any hypother mia (N = 8, Fig. 9 ). Abbreviations: FC, frontal cortex; TC, temporal cortex; DH, dorsal hippocampus; VH, ventral hippo campus; VMH, ventromedial hypothalamus; LH, lateral hypothalamus; AME, medial amygdala. Mean ± S.E. *P < 0.05, **P < 0.01, ***P < 0.001 vs. scopolamine; ttp < 0 01 tttP < 0.001 vs. vehicle.
DISCUSSION
Alzheimer's senile dementia is frequently accompanied by hypofunction of the brain acetylcholinergic neural systems (16, 17) . This hypofunction is expressed by an impairment of some mental activities including speech, mem ory, visual space perception, personality and cognition (abstract ability, calculation ability and judgement) (16) . Among some indi viduals, an impairment of time and spatial orientation also appears at an initial stage. It is well-known that scopolamine, a mus carinic ACh receptor blocker, markedly dis rupts spatial cognition such as that acquired by rats in this study. Scopolamine also disrupts passive avoidance performance in rats and mice (18) . The cholinergic involvement of memory and learning was well-demonstrated because cell loss in the nucleus basalis of Meynert, a source of the extrinsic cholinergic input to the cortex and amygdala, and cell loss in the medial sept/diagonal band complex, a source of cholinergic input to the hippocam pus, are characteristic of human aging and occur to a much greater extent in Alzheimer's disease (19) . In animal studies, lesions of either the septal area or nucleus basalis also impaired memory and learning (20) . Scopolamine-induced disruption was shown to be markedly reversed by the ACh esterase in hibitor physostigmine or catecholaminergic drugs such as amantadine (9) . Furthermore, our previous report indicated that the ame liorative effect of amantadine is inhibited by prazosin, a noradrenergic a,-receptor blocker (9) . Noradrenergic involvement in memory and learning was also suggested because it shows an age-related decline, with moderate to severe additional deterioration in Alzheim er's disease (21, 22) . Furthermore, the cell numbers of the locus coeruleus, which pro vides noradrenergic innervation of the cortex and hippocampus, appears to be particularly affected by age and disease (23) . Thus, the available data suggest the importance of the brain noradrenergic system as well as the cho linergic nervous system in learning and mem ory.
Therefore, we first studied the effect of neb racetam on scopolamine-induced disruption of spatial cognition in rats and compared it with that of aniracetam. Nebracetam reversed the scopolamine-induced disruption of spatial cognition. This improvement effect was also considered to be due to the stimulation of the acetylcholinergic systems because nebracetam had an affinity for muscarinic M1-receptors in vitro and can potentiate ACh synthesis (12) . Furthermore, to observe whether nebracetam had a cholinergic stimulating effect, the effect of nebracetam on the tremor induced by oxo tremorine which had a stimulating effect on central muscarinic-receptors (24, 25) was ex amined using mice. Nebracetam potentiated oxotremorine-induced tremors at a dose of 10 mg/kg, i.p. because this dose should stimulate both the M1-receptors and ACh synthesis. However, nebracetam did not potentiate this tremor at higher doses. This diminishing effect of the higher dose of the drug might be due to a negative feed-back mechanism by the in creased ACh release (25) .
The retrieval effect of nebracetam on the disruption of spatial cognition in rats, how ever, was in an inverted-U dose-dependent manner. This mode of action was also observed in the treatments with noradrenergic, sero tonergic and cholinergic agonists (9) (10) (11) . This means that the optimal dose must be used to obtain an improvement of cognitive disrup tion. Furthermore, multiple neurotransmitter balances may also play an important role in the performance of spatial cognitions such as higher brain functions. From this evidence, higher doses of nebracetam are suggested to induce imbalances of multiple neurotransmit ter interactions including interactions between the cholinergic and noradrenergic systems.
Aniracetam improved the scopolamine-in duced disruption of spatial cognition and this ameliorative effect of aniracetam might be due to the same mechanism as that of nebracetam.
In the above-described experiments, we in vestigated whether nebracetam acted through a noradrenergic mechanism to decrease scopolamine-induced disruption of spatial cognition. Previous reports have suggested that nebracetam had noradrenergic antide pressant profiles because of its antagonism of tetrabenazine-ptosis, distress call activation and central 8-receptor down regulation (12) . In addition, at higher doses, nebracetam tended to increase NA release and/or turn over (26) . Our previous report also indicated that antidepressants such as desipramine or imipramine improve scopolamine-induced dis ruption of spatial cognition at a dose that had no anti-cholinergic effects (9, 10) .
In the present biochemical studies, brain NA contents in various brain regions were stud ied using HPLC-ECD. In rats with impaired spatial cognition induced by scopolamine, brain NA levels were decreased in the frontal cortex, dorsal and ventral hippocampus and the amygdala complex. Nebracetam normal ized the decreased NA levels in these area. One of the mechanisms in spatial cognition was also reported to be present in the brain noradrenergic system. Amantadine or L-threo DOPS, which have no cholinergic enhancing effects, improved the disruption of spatial cognition (9) . These results may also be due to brain noradrenergic function. Interesting ly, in the present study, the normalizing effect of nebracetam on brain NA levels was observed only in the areas that are considered to be important for memory and learning. Nebracetam, as well as these drugs, may ame liorate the disrupted spatial cognition via noradrenergic systems in either the frontal cortex or other lymbic systems.
In addition, THC, which is known to cause a marked orientation impairment in humans, remarkably impaired the radial maze perform ance of rats as well. The characteristic features of THC-induced disruption of spatial cognition were reported to be different from those of the scopolamine-induced one (11) . The THC induced disruption of spatial cognition was also improved by noradrenergic or seroton ergic compounds, while antidepressants such as desipramine etc. did not affect the THC-in duced spatial disruption (11) . This impairment was reversed by nebracetam as well as physo stigmine and amantadine which had previously been reported to be highly effective (9) . These results also suggest that nebracetam also oper ates through a noradrenergic mechanism to re verse spatial disruption. Aniracetam also de creased the THC-induced disruption of spatial cognition like nebracetam, but was more effective.
Finally, the present study on behavioral tox icity suggested that nebracetam, even in high doses, did not affect spontaneous motor activ 
